BR112023001832A2 - Composto cicloalquenona ou sal do mesmo - Google Patents
Composto cicloalquenona ou sal do mesmoInfo
- Publication number
- BR112023001832A2 BR112023001832A2 BR112023001832A BR112023001832A BR112023001832A2 BR 112023001832 A2 BR112023001832 A2 BR 112023001832A2 BR 112023001832 A BR112023001832 A BR 112023001832A BR 112023001832 A BR112023001832 A BR 112023001832A BR 112023001832 A2 BR112023001832 A2 BR 112023001832A2
- Authority
- BR
- Brazil
- Prior art keywords
- salt
- compound
- active ingredient
- therapeutic agent
- cycloalkenone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/31—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020135328 | 2020-08-07 | ||
| PCT/JP2021/029246 WO2022030606A1 (ja) | 2020-08-07 | 2021-08-06 | 新規なシクロアルケノン化合物又はその塩 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023001832A2 true BR112023001832A2 (pt) | 2023-02-23 |
Family
ID=80118163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023001832A BR112023001832A2 (pt) | 2020-08-07 | 2021-08-06 | Composto cicloalquenona ou sal do mesmo |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230295068A1 (https=) |
| EP (1) | EP4194435A4 (https=) |
| JP (1) | JP7109705B2 (https=) |
| KR (1) | KR20230043923A (https=) |
| CN (1) | CN116096361B (https=) |
| AU (1) | AU2021321705B2 (https=) |
| BR (1) | BR112023001832A2 (https=) |
| CA (1) | CA3188292A1 (https=) |
| MX (1) | MX2023001536A (https=) |
| TW (1) | TWI829001B (https=) |
| WO (1) | WO2022030606A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4477642A4 (en) * | 2022-02-09 | 2026-02-25 | Taiho Pharmaceutical Co Ltd | CRYSTALLINE FORM OF CYCLOHEXENONE COMPOUND |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6228893B1 (en) * | 1997-08-13 | 2001-05-08 | Meiji Milk Products Co., Ltd. | Cyclohexenone long-chain alcohol and medicament containing same |
| JP3836684B2 (ja) | 2001-02-19 | 2006-10-25 | 明治乳業株式会社 | 排尿障害治療剤 |
| WO2009111576A2 (en) | 2008-03-05 | 2009-09-11 | Edison Pharmaceuticals, Inc. | 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES |
| CA2883879A1 (en) | 2012-09-07 | 2014-03-13 | Edison Pharmaceuticals, Inc. | Quinone derivatives for use in the modulation of redox status of individuals |
| WO2017106803A1 (en) | 2015-12-17 | 2017-06-22 | Bioelectron Technology Corporation | Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders |
| ES2849425T3 (es) | 2016-01-22 | 2021-08-18 | Taiho Pharmaceutical Co Ltd | Método de fabricación de alcohol de cadena larga de ciclohexenona de alta pureza |
| TWI831738B (zh) * | 2016-12-16 | 2024-02-11 | 美商瑞塔醫藥有限責任公司 | 用於抑制ＲＯＲγ及其他用途的嘧啶三環烯酮衍生物 |
-
2021
- 2021-08-06 KR KR1020237006213A patent/KR20230043923A/ko active Pending
- 2021-08-06 AU AU2021321705A patent/AU2021321705B2/en active Active
- 2021-08-06 WO PCT/JP2021/029246 patent/WO2022030606A1/ja not_active Ceased
- 2021-08-06 JP JP2022518890A patent/JP7109705B2/ja active Active
- 2021-08-06 US US18/040,862 patent/US20230295068A1/en active Pending
- 2021-08-06 TW TW110129168A patent/TWI829001B/zh active
- 2021-08-06 BR BR112023001832A patent/BR112023001832A2/pt unknown
- 2021-08-06 MX MX2023001536A patent/MX2023001536A/es unknown
- 2021-08-06 CA CA3188292A patent/CA3188292A1/en active Pending
- 2021-08-06 EP EP21853226.5A patent/EP4194435A4/en active Pending
- 2021-08-06 CN CN202180057124.1A patent/CN116096361B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3188292A1 (en) | 2022-02-10 |
| TW202216650A (zh) | 2022-05-01 |
| US20230295068A1 (en) | 2023-09-21 |
| JP7109705B2 (ja) | 2022-07-29 |
| TWI829001B (zh) | 2024-01-11 |
| MX2023001536A (es) | 2023-03-08 |
| WO2022030606A1 (ja) | 2022-02-10 |
| KR20230043923A (ko) | 2023-03-31 |
| JPWO2022030606A1 (https=) | 2022-02-10 |
| CN116096361A (zh) | 2023-05-09 |
| EP4194435A1 (en) | 2023-06-14 |
| AU2021321705B2 (en) | 2024-02-29 |
| AU2021321705A1 (en) | 2023-03-09 |
| EP4194435A4 (en) | 2024-09-25 |
| CN116096361B (zh) | 2025-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022024120A2 (pt) | Derivado de piridina-pirimidina, método de preparação do mesmo e uso farmacêutico do mesmo | |
| BR112021009595A2 (pt) | Terapia de combinação incluindo um inibidor de krasg12c e um ou mais agentes farmaceuticamente ativos adicionais para o tratamento de cânceres | |
| CR20210563A (es) | Compuestos y métodos para el tratamiento de covid-19 | |
| BR112022002520A2 (pt) | Piperidinil-metil-purina-aminas como inibidores de nsd2 e agentes anticâncer | |
| MX2012012225A (es) | Profármacos de agentes tearapéuticos de liberación de óxido nítrico. | |
| BR112019024831A2 (pt) | composto, sal, solvato ou pró-droga, composição farmacêutica, método de tratamento ou prevenção de uma doença, método para inibir o nlrp3 | |
| PH12020551751A1 (en) | 2-amino-2-(1,2,3-triazole-4-yl)propane-1,3-diol derivative of novel compound for directly inhibiting asm activity, and use thereof | |
| BR112014004845A2 (pt) | pelo menos uma entidade química; pelo menos um composto; composição farmacêutica; uso de uma quantidade terapeuticamente eficaz de pelo menos uma entidade química; composição farmacêutica embalada | |
| PH12014502218A1 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| BR112014004741A2 (pt) | pelo menos uma entidade química; composição farmacêutica; uso de uma quantidade terapeuticamente eficaz de pelo menos uma entidade química; composição farmacêutica embalada | |
| MX2024002696A (es) | Derivados del acido 2-amino-5,5-dimetilhexanoico como moduladores de sortilina para su uso en el tratamiento de enfermedades del sistema nervioso central. | |
| MX2023013972A (es) | Compuesto de quinolinamina, metodo de preparacion y aplicacion del mismo en productos farmaceuticos. | |
| ZA202210355B (en) | Compositions and therapeutic uses of cannabidiol | |
| PH12019500618A1 (en) | Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease | |
| EP3791869A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASES WITH COX2 ACETYLATING AGENT AS THE ACTIVE SUBSTANCE | |
| BRPI0713743C1 (pt) | composto, e, composição farmacêutica | |
| BR112014031649A2 (pt) | composto representado pela fórmula 1 tendo a enzima inibidora de atividade 11b-hsd1; método para sua produção e composição farmacêutica contendo o mesmo como ingrediente ativo | |
| BRPI0607536A2 (pt) | tratamento de dor | |
| BR112023001832A2 (pt) | Composto cicloalquenona ou sal do mesmo | |
| AR120717A1 (es) | Análogos de insulina y usos de los mismos | |
| BR112014029597A2 (pt) | compostos de cromano | |
| BR112023023513A2 (pt) | Composto de pirazolopirimidina para o tratamento de distúrbios dérmicos | |
| EP4620940A3 (en) | Synthesis of (+)-cannabinoids and their therapeutic effects | |
| BR112022012368A2 (pt) | Composto, e, composição farmacêutica para o tratamento de doenças associadas a diacilglicerol aciltransferase 2 | |
| BR112014026535A2 (pt) | derivado de ácido trans-2-decenoico e fármaco contendo o mesmo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |